10-102424269-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024040.3(CUEDC2):c.406G>A(p.Asp136Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,613,476 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024040.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CUEDC2 | ENST00000369937.5 | c.406G>A | p.Asp136Asn | missense_variant | Exon 5 of 9 | 1 | NM_024040.3 | ENSP00000358953.4 | ||
CUEDC2 | ENST00000465409.1 | n.36G>A | non_coding_transcript_exon_variant | Exon 1 of 3 | 2 | |||||
CUEDC2 | ENST00000477994.1 | n.475G>A | non_coding_transcript_exon_variant | Exon 5 of 5 | 2 | |||||
CUEDC2 | ENST00000486762.6 | n.375G>A | non_coding_transcript_exon_variant | Exon 4 of 5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248852Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134996
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461272Hom.: 0 Cov.: 34 AF XY: 0.0000220 AC XY: 16AN XY: 726942
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152204Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.406G>A (p.D136N) alteration is located in exon 5 (coding exon 4) of the CUEDC2 gene. This alteration results from a G to A substitution at nucleotide position 406, causing the aspartic acid (D) at amino acid position 136 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at